Your browser doesn't support javascript.
loading
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.
Sandecka, Viera; Popkova, Tereza; Stork, Martin; Maisnar, Vladimir; Minarik, Jiri; Jungova, Alexandra; Pavlicek, Petr; Stejskal, Lukas; Pospisilova, Lenka; Heindorfer, Adriana; Obernauerova, Jarmila; Gregora, Evzen; Sykora, Michal; Ullrychova, Jana; Wrobel, Marek; Kessler, Petr; Jelinek, Tomas; Kunovszki, Peter; Bathija, Sacheeta; Gros, Blanca; Wilbertz, Sabine; Cai, Qian; Lam, Annette; Spicka, Ivan.
Afiliação
  • Sandecka V; University Hospital Brno, Brno, Czech Republic.
  • Popkova T; University Hospital Ostrava and Faculty of Medicine, Ostrava, Czech Republic.
  • Stork M; University Hospital Brno, Brno, Czech Republic.
  • Maisnar V; Charles University Hospital and Faculty of Medicine Hradec Kralove, Hradec Kralove, Czech Republic.
  • Minarik J; University Hospital Olomouc, Olomouc, Czech Republic.
  • Jungova A; University Hospital Pilsen, Pilsen, Czech Republic.
  • Pavlicek P; University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Stejskal L; Silesian Hospital in Opava, Opava, Czech Republic.
  • Pospisilova L; Institute of Biostatistics and Analyses Ltd, Brno, Czech Republic.
  • Heindorfer A; Liberec Regional Hospital, Liberec, Czech Republic.
  • Obernauerova J; Regional Hospital Mlada Boleslav, Mlada Boleslav, Czech Republic.
  • Gregora E; Motol University Hospital, Prague, Czech Republic.
  • Sykora M; Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic.
  • Ullrychova J; KZ, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic.
  • Wrobel M; Hospital Novy Jicin, Novy Jicin, Czech Republic.
  • Kessler P; Hospital Pelhrimov, Pelhrimov, Czech Republic.
  • Jelinek T; University Hospital Ostrava and Faculty of Medicine, Ostrava, Czech Republic.
  • Kunovszki P; Janssen Global Services, Budapest, Hungary.
  • Bathija S; Janssen Global Services, Raritan, NJ, USA.
  • Gros B; Janssen-Cilag, Madrid, Spain.
  • Wilbertz S; Janssen-Cilag GmbH, Neuss, Germany.
  • Cai Q; Janssen Global Services, Titusville, NJ, USA.
  • Lam A; Janssen Global Services, Raritan, NJ, USA.
  • Spicka I; Charles University and General Hospital in Prague, Prague, Czech Republic. spicka@cesnet.cz.
Blood Cancer J ; 13(1): 153, 2023 09 27.
Article em En | MEDLINE | ID: mdl-37752128

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Latente / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Latente / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: República Tcheca